INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44m ago
HOUSE PTR3m ago
SEC 13F3m ago
ROBINHOOD CHAIN3m ago
SEC FORM 4/Disposition to issuerVerified data

Brun Scott C. reported FBRX

Director · Forte Biosciences, Inc. · Forte Biosciences, Inc. — Restricted Stock Units

Side
D
Value
—
Shares
18.4K
Price
—
Executed
Aug 27, 2026
Disclosed
Aug 27, 2026
Disclosure timeline0 days from execution to publication · legal deadline 2 business days
Aug 27 executedAug 27, 2026 disclosed

FBRX · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Disposition to issuer — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 0 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · FBRX

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    KS
    Kapoor Shivpreet SinghDirector
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    18.4K sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KS
    Kapoor Shivpreet SinghDirector
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    2,000 sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KS
    Kapoor Shivpreet SinghDirector
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    31.0K sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    BC
    Brun Scott C.Director
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    2,000 sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    BC
    Brun Scott C.Director
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    2,000 sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    BC
    Brun Scott C.Director
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    31.0K sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KS
    Kornfeld StevenDirector
    FBRXForte Biosciences, Inc.
    Tender of shares
    		U—
    3,960 sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KS
    Kornfeld StevenDirector
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    1,200 sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KS
    Kornfeld StevenDirector
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    800 sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KS
    Kornfeld StevenDirector
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    1,000 sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KS
    Kornfeld StevenDirector
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    1,000 sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KS
    Kornfeld StevenDirector
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    1,000 sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KS
    Kornfeld StevenDirector
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    2,000 sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KS
    Kornfeld StevenDirector
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    31.0K sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KS
    Kornfeld StevenDirector
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    18.4K sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    BC
    Brun Scott C.Director
    FBRXForte Biosciences, Inc.
    Disposition to issuer
    		D—
    1,000 sh
    		Aug 27, 2026Aug 27, 2026
    traded Aug 27, 2026
    		+0dSEC FORM 4

    Evidence

    9
    KS
    Kapoor Shivpreet SinghDirector
    FBRXForte Biosciences, Inc.
    Grant or award
    		A—
    18.4K sh
    		May 29, 2026Jun 2, 2026
    traded May 29, 2026
    		+4dSEC FORM 4

    Evidence

    9
    WA
    Wagner Paul A.Director, SEE REMARKS
    FBRXForte Biosciences, Inc.
    Grant or award
    		A—
    180.0K sh
    		Jan 12, 2026Jan 13, 2026
    traded Jan 12, 2026
    		+1dSEC FORM 4

    Evidence

    9
    WA
    Wagner Paul A.Director, SEE REMARKS
    FBRXForte Biosciences, Inc.
    Grant or award
    		A—
    270.0K sh
    		Jan 12, 2026Jan 13, 2026
    traded Jan 12, 2026
    		+1dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001863614-26-000003
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Aug 27, 2026
    Published
    Aug 27, 2026
    Ingested by INSIDER
    Nov 5, 02:20 UTC
    Last re-read
    Nov 5, 02:20 UTC

    Extracted facts

    Filer
    Brun Scott C.
    Role
    Director
    Transaction
    Disposition to issuerAs filed: “D”
    Asset
    Forte Biosciences, Inc. — Restricted Stock Units
    Ticker
    FBRX
    Shares
    18.4K
    Execution date (reported)
    Aug 27, 2026
    Owned after transaction
    0 shares
    Days from execution to publication
    0

    What this establishes

    Brun Scott C. filed this Form 4 reporting a disposition to issuer of FBRX on Aug 27, 2026. It became public on Aug 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Director
    Brun Scott C.cik:0001863614
    Issuer
    Forte Biosciences, Inc.cik:0001419041

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.